Projecten per jaar
Persoonlijk profiel
Expertise
- Manufacturing and screening of monoclonal antibodies against human cell membranes and proteins. Sorting cells on FACS-sorter. DNA analysis using gen probes for clinical purposes. Orders for third parties have been executed. Delays may be discussed and depend on the demand.
Vingerafdruk
- 1 Soortgelijke profielen
-
-
GIFT99: Giftenrekening. Tijdelijke-Leestoel-op naam (Titularis Prof Rik Schots): Roche Chair in Hematology.
1/01/07 → 30/06/09
Project: Fundamenteel
-
FWOAL374: Tumor-micromilieu interacties als therapeutisch doelwit in multiple myeloma.
Van Camp, B., Vanderkerken, K. & Van Riet, I.
1/01/06 → 31/12/09
Project: Fundamenteel
-
FWOTM376: Interactie tussen het embryo en NK cellen in het endometrium : rol bij implantatiestoornissen.
Vercammen, M., De Waele, M. & Van Camp, B.
1/10/05 → 30/09/10
Project: Fundamenteel
-
OZR1141: CD45 subsets in multiple myeloma; betrokkenheid bij osteolytisch botafbraak, hun differentiatie en differentiële genexpressieprofiel.
Van Camp, B. & Asosingh, K.
1/01/05 → 31/12/05
Project: Fundamenteel
Onderzoeksoutput
-
Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro (vol 12, pg 1763, 2013)
Hu, J., Van Valckenborgh, E., Xu, D., Menu, E., De Raeve, H., De Bruyne, E., Xu, S., Van Camp, B., Handisides, D., Hart, C. P. & Vanderkerken, K., jul 2015, In: Molecular Cancer Therapeutics. 14, 7, blz. 1762-1762 1 blz.Onderzoeksoutput: Article › peer review
-
IMWG consensus on risk stratification in multiple myeloma
Chng, W., Dispenzieri, A., Chim, C. S., Schots, H., Van Camp, B., Van Riet, I., Vande Broek, I. & Vanderkerken, K., 5 feb 2014, In: Leukemia. 28, blz. 269-277Onderzoeksoutput: Article › peer review
522 Citaten (Scopus) -
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo
Xu, S., De Veirman, K., Evans, H. R., Santini, G., Vande Broek, I., Leleu, X., De Becker, A., Van Camp, B., Croucher, P. I., Vanderkerken, K. & Van Riet, I., 8 apr 2013, In: Acta Pharmacol Sin.. 34, 5, blz. 699-709Onderzoeksoutput: Article › peer review
56 Citaten (Scopus) -
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Fernández De Larrea, C., Kyle, R., Durie, B., Ludwig, H., Usmani, S., Vesole, D., San Miguel, J. F., Sezer, O., Sonneveld, P., Kumar, S., Mahindra, A., Anderson, K., Schots, H., Van Camp, B., Van Riet, I., Vande Broek, I. & Vanderkerken, K., 1 apr 2013, In: Leukemia. 27, 4, blz. 780-791Onderzoeksoutput: Article › peer review
285 Citaten (Scopus) -
Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro.
Hu, J., Van Valckenborgh, E., Xu, D., Menu, E., De Raeve, H., De Bruyne, E., Xu, S., Van Camp, B., Handisides, D. R., Hart, C. & Vanderkerken, K., 5 jul 2013, In: Mol Cancer Ther. 12, 9, blz. 1763-1773 11 blz.Onderzoeksoutput: Article › peer review
47 Citaten (Scopus)
Prijzen
-
Binnenlandse Franqui-leerstoel 2000-2001
Van Camp, Benjamin (Recipient), 2001
Prijs: Prize (including medals and awards)
Activiteiten
-
13th International Myeloma Workshop
Benjamin Van Camp (Participant)
3 mei 2011 → 6 mei 2011Activiteit: Participation in workshop, seminar
-
XII International Myeloma Workshop
Benjamin Van Camp (Participant)
26 feb 2009 → 1 mrt 2009Activiteit: Participation in workshop, seminar
-
10th International Myeloma Workshop, 10-14 april 2005, Sydney.
Benjamin Van Camp (Keynote speaker)
10 apr 2005 → 14 apr 2005Activiteit: Talk or presentation at a workshop/seminar
-
Cell signaling, transcription and translation as therapeutic targets
Benjamin Van Camp (Participant)
2002Activiteit: Participation in conference
-
Koninklijke Academie voor Geneeskunde (Externe Organisatie)
Benjamin Van Camp (Contributor)
1 jan 2002Activiteit: Membership of external research organisation